SFX by Ex Libris Inc.

Title:	Failure of the cystic fibrosis transmembrane conductance regulator to conduct ATP
Source:	Science [0036-8075] Reddy, M M yr:1996

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Harada, M. "Target molecules in specific immunotherapy against prostate cancer." International journal of clinical oncology 8.4 (2003): 193-9.
description	2.	Lamhonwah, A. "Cystic fibrosis transmembrane conductance regulator in human muscle: Dysfunction causes abnormal metabolic recovery in exercise." Annals of neurology 67.6 (2010): 802-8.
description	3.	Cantiello, I L F. "The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel." The Journal of biological chemistry 269.32 (1994): 20584-91.
description	4.	COLLINS, F. "CYSTIC-FIBROSIS - MOLECULAR-BIOLOGY AND THERAPEUTIC IMPLICATIONS." Science 256.5058 (1992): 774-779.
description	5.	Quinton, P M M. "Control of CFTR chloride conductance by ATP levels through non-hydrolytic binding." Nature 360.6399 (1992): 79-81.
description	6.	ROWE, STEVEN M. "Cystic Fibrosis." The New England journal of medicine 352.19 (2005): 1992-2001.
description	7.	Fong, L. "Immunotherapy for prostate cancer." Seminars in oncology 30.5: 649-658.
description	8.	Dubbink, H J J. "The human prostate-specific transglutaminase gene (TGM4): genomic organization, tissue-specific expression, and promoter characterization." Genomics 51.3 (1998): 434-44.
description	9.	Tsui, L C C. "Cystic fibrosis: genotypic and phenotypic variations." Annual review of genetics 29.1 (1995): 777-807.
description	10.	Reddy, M M. "Retention of basic electrophysiologic properties by human sweat duct cells in primary culture." In vitro cellular & developmental biology (1988): 905-910.
description	11.	ABRAHAM, E. "THE MULTIDRUG RESISTANCE (MDR1) GENE-PRODUCT FUNCTIONS AS AN ATP CHANNEL." Proceedings of the National Academy of Sciences of the United States of America 90.1 (1993): 312-316.
description	12.	Cataln, Marcelo A. "Cftr and ENaC Ion Channels Mediate NaCl Absorption in the Mouse Submandibular Gland." The Journal of physiology 588.4 (2009): 713-724.
description	13.	Huyard, C. "What, if anything, is specific about having a rare disorder? Patients' judgements on being ill and being rare." Health expectations 12.4 (2009): 361-370.
description	14.	Fong, L. "Immunotherapy for prostate cancer." Current Oncology Reports 9.3 (2007): 226-33.
description	15.	Casaulta-Aebischer, C H. "Nutrition and lung function in cystic fibrosis patients: review." Clinical Nutrition 19.2 (2000): 79-85.
description	16.	Milani, S. "Growth and long-term lung function in cystic fibrosis: A longitudinal study of patients diagnosed by neonatal screening." Pediatric pulmonology 44.3 (2009): 209-215.
description	17.	Dalgleish, A G G. "Cancer vaccines as a therapeutic modality: The long trek." Cancer immunology, immunotherapy 55.8 (2006): 1025-32.
description	18.	Gentzsch, M R. "Misassembled mutant {Delta}F508 CFTR in the distal secretory pathway alters cellular lipid trafficking." Journal of cell science 120.Pt 3 (2007): 447-55.
description	19.	Xie, J. "Intracellular loop between transmembrane segments IV and V of cystic fibrosis transmembrane conductance regulator is involved in regulation of chloride channel conductance state." The Journal of biological chemistry (1995): 28084-91.
description	20.	Stutts, M J J. "CFTR as a cAMP-dependent regulator of sodium channels." Science 269.5225: 847-850.